Kühhorn J, Götz A, Hübner H, Thompson D, Whistler J, Gmeiner P (2011)
Publication Language: English
Publication Type: Journal article, Original article
Publication year: 2011
Original Authors: Kuhhorn J., Gotz A., Hubner H., Thompson D., Whistler J., Gmeiner P.
Publisher: American Chemical Society
Book Volume: 54
Pages Range: 7911-7919
Journal Issue: 22
DOI: 10.1021/jm2009919
Bivalent D agonists may function as useful molecular probes for the discovery of novel neurological therapeutics. On the basis of our recently developed bivalent dopamine D receptor antagonists of type 1, the bivalent agonist 2 was synthesized when a spacer built from 22 atoms was employed. Compared to the monovalent control compound 6 containing a capped spacer, the bis-aminoindane derivative 2 revealed substantial steepening of the competition curve, indicating a bivalent binding mode. Dimer-specific Hill slopes were not a result of varying functional properties because both the dopaminergic 2 and the monovalent control agent 6 proved to be D agonists substantially inhibiting cAMP accumulation and inducing D receptor internalization. Investigation of the heterobivalent ligands 8 and 9, containing an agonist and a phenylpiperazine-based antagonist pharmacophore, revealed moderate steepening of the displacement curves and antagonist to very weak partial agonist properties. © 2011 American Chemical Society.
APA:
Kühhorn, J., Götz, A., Hübner, H., Thompson, D., Whistler, J., & Gmeiner, P. (2011). Development of a bivalent dopamine D2 receptor agonist. Journal of Medicinal Chemistry, 54(22), 7911-7919. https://doi.org/10.1021/jm2009919
MLA:
Kühhorn, Julia, et al. "Development of a bivalent dopamine D2 receptor agonist." Journal of Medicinal Chemistry 54.22 (2011): 7911-7919.
BibTeX: Download